F.NO. 8 (6)/2006/DP/NPPA-Div.II
GOVERNMENT OF INDIA
MINISTRY OF CHEMICALS AND FERTILIZERS
NATIONAL PHARMACEUTICAL PRICING AUTHORITY
NEW DELHI, DATED THE 29/11/2006
ORDER
In exercise of the powers, conferred by sub-paragraph (1)/(2)/(4) of paragraph 8 of the Drugs (Price Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority hereby fixes/revises the prices as specified in column (5) of the Table hereto annexed as the retail price/revised retail price, exclusive of excise duty, sales taxes/VAT and local taxes, if any, in relation to each of the formulations specified in the corresponding entry in column (2) of the said Table with pack size specified in the corresponding entries in column (3) thereof;
TABLE
| Sl. No. | Name of the Formulation | Pack Size | Existing Retail Price (Rs.) |
Retail Price without Excise Duty, Sales Tax/VAT and Local Tax, if any (Rs.) |
|---|---|---|---|---|
| 1 | Insulatard HM Penfill 100IU Highly Purified Isophane Insulin Suspension (Monocomponent Human) Insulatard HM Penfill -100IU/ml Batch No. SW1399,Qty. 740 |
5x3ml Cartridge | 1044.70 | 1109.26 |
| 2 | Mixtard 30HM Penfill 100IU Mixture of Highly Purified Neutral Insulin Solution and Isophane Suspension (Monocomponent Human) Human Mixtard 30HM Penfill -100IU/ml Batch No. SW1358,Qty. 739 |
5x3ml Cartridge | 1044.70 | 1109.26 |
| 3 | Mixtard 50HM Penfill 100IU Mixture of Highly Purified Neutral Insulin Solution and Isophane Suspension (Monocomponent Human) Mixtard 50HM Penfill -100IU/ml Batch No. SW1402,Qty. 741 |
5x3ml Cartridge | 1044.70 | 1109.26 |
| 4 | Actrapid HM Penfill 100IU Highly Purified Neutral Insulin (Monocomponent Human) Actrapid HM Penfill -100IU/ml Batch No. SW1353,Qty. 744 |
5x3ml Cartridge | 1044.70 | 1109.26 |
| 5 | Mixtard 30 Novolet Mixture of Biosynthetic Neutral Human Insulin Solution (30%) and Isophane insulin Suspension (70%) – 100 IU/ml in 3ml precision delivery device Batch No. SP51463,Qty. 1458 |
5x3ml Cartridge | 1305.90 | 1518.98 |
| 6 | Actrapid Novolet Biosynthetic Neutral Human Insulin 100Iu/ml in 3ml precision delivery device Batch No. SP51506,Qty. 1356 |
5x3ml Cartridge | 1305.90 | 1518.98 |
| 7 | Mixtard 50 Novolet Mixture of Biosynthetic Neutral Human Insulin Solution (50%) and Isophane insulin Suspension (50%) – 100 IU/ml in 3ml precision delivery device Batch No. SP51520,Qty. 1338 |
5x3ml Cartridge | 1305.90 | 1518.98 |
| 8 | Insulatard Novolet Biosynthetic Human Isophane Insulin Suspension 100IU/ml in 3ml precision delivery device Batch No. SP51483,Qty. 1284 |
5x3ml Cartridge | 1305.90 | 1518.98 |
- This order shall be applicable if the manufacturer of the formulation specified in column (2) of the Table above has complied with the requirements, if any, of
(a) the Drugs and Cosmetics Act, 1940 (23 of 1940) and the rules made thereunder; and
(b) the Industries (Development and Regulation) Act, 1951 (65 of 1951) as amended from time to time.
3.(a) Excise Duty, sales taxes/VAT and local taxes, if any, shall be worked out by the company concerned as per the rate applicable and added in the retail price / revised retail price specified in column no (5) of the above table to arrive at the MRP inclusive of all taxes.
(b) The prices fixed/revised is the Maximum Retail Prices (excluding of excise duty, sales taxes/VAT and of local taxes, if any) for the specified pack and packs of similar strength. Companies cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(c) For different packing material used or any special feature claimed, companies are required to approach NPPA for approval/fixation of specific prices.
- These prices/revised prices shall be made effective within 15 days of receipt of this order as required under sub para 14(1) of DPCO, 1995. The necessary price-list should also be issued as required under sub-paragraph (3) of paragraph 14 of the Drugs (Prices Control) Order, 1995.
(A. K. PAL)
Dy. Director
PN/90/2006/F
M/s. Novo Nordisk (India) Pvt. Ltd.
Last Page Updated: 07-06-2019
Copyright © 2023 - All Rights Reserved- Official Website of National Pharmaceutical Pricing Authority Ministry of Chemicals and Fertilizers, Government of India
Note :Website Content Managed by National Pharmaceutical Pricing Authority Ministry of Chemicals and Fertilizers, Designed, Developed and Hosted by National Informatics Centre Services Inc.(NICSI)